Sergio Padilla

5.0k total citations
118 papers, 3.3k citations indexed

About

Sergio Padilla is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Sergio Padilla has authored 118 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 32 papers in Emergency Medicine and 26 papers in Virology. Recurrent topics in Sergio Padilla's work include HIV-related health complications and treatments (30 papers), HIV Research and Treatment (25 papers) and HIV/AIDS drug development and treatment (25 papers). Sergio Padilla is often cited by papers focused on HIV-related health complications and treatments (30 papers), HIV Research and Treatment (25 papers) and HIV/AIDS drug development and treatment (25 papers). Sergio Padilla collaborates with scholars based in Spain, United States and Mexico. Sergio Padilla's co-authors include Mar Masiá, Félix Gutiérrez, José Manuel Ramos, Ildefonso Hernández‐Aguado, Lorena García‐Fernández, Roberto Rodríguez–Jiménez, Verónica Romero‐Ferreiro, Carlos Santos‐Ocaña, Juan Carlos Rodrı́guez and Marta Fernández‐González and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sergio Padilla

113 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergio Padilla Spain	34	1.3k	905	764	577	506	118	3.3k
Gabriella d’Ettorre Italy	34	1.9k 1.5×	903 1.0×	691 0.9×	1.4k 2.5×	850 1.7×	262	4.7k
Alessandra Bandera Italy	31	1.7k 1.3×	951 1.1×	372 0.5×	640 1.1×	478 0.9×	187	3.2k
Susanne Dam Nielsen Denmark	35	1.5k 1.2×	1.2k 1.3×	1.0k 1.4×	980 1.7×	858 1.7×	291	5.5k
Qiuhu Shi United States	34	1.7k 1.3×	1.3k 1.4×	1.2k 1.6×	433 0.8×	454 0.9×	169	4.4k
Annalisa Saracino Italy	29	1.5k 1.2×	981 1.1×	497 0.7×	703 1.2×	186 0.4×	212	3.2k
Michael T. Yin United States	40	2.3k 1.8×	907 1.0×	2.4k 3.1×	660 1.1×	620 1.2×	210	5.7k
Nancy F. Crum‐Cianflone United States	45	2.3k 1.8×	2.2k 2.4×	1.1k 1.5×	1.1k 1.8×	391 0.8×	153	5.7k
Samantha MaWhinney United States	37	1.5k 1.2×	925 1.0×	832 1.1×	1.4k 2.5×	628 1.2×	143	4.6k
Anders Boyd Netherlands	33	1.0k 0.8×	1.7k 1.9×	184 0.2×	205 0.4×	587 1.2×	229	3.8k
Rita Murri Italy	40	3.1k 2.4×	1.4k 1.6×	1.0k 1.4×	1.5k 2.6×	159 0.3×	153	5.0k

Countries citing papers authored by Sergio Padilla

Since Specialization

Citations

This map shows the geographic impact of Sergio Padilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Padilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Padilla more than expected).

Fields of papers citing papers by Sergio Padilla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Padilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Padilla. The network helps show where Sergio Padilla may publish in the future.

Co-authorship network of co-authors of Sergio Padilla

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Padilla. A scholar is included among the top collaborators of Sergio Padilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Padilla. Sergio Padilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernández‐González, Marta, Guillermo Telenti, Enrique Barrajón‐Catalán, et al.. (2025). Influence of patient characteristics and oral lead-in on long-acting cabotegravir and rilpivirine pharmacokinetics and outcomes in people with HIV: a real-world study. Antimicrobial Agents and Chemotherapy. 69(7). e0014525–e0014525. 2 indexed citations

Belló-Pérez, Melissa, Marta Fernández‐González, José Alberto García, et al.. (2025). ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal anal cytology. International Journal of Cancer. 157(9). 1939–1947. 1 indexed citations

Gutiérrez, Félix, Marta Fernández‐González, Javier García‐Abellán, et al.. (2025). Virological Success With Long-Acting Cabotegravir and Rilpivirine Despite Historical Rilpivirine Resistance: A Real-World Case Series. Open Forum Infectious Diseases. 12(11). ofaf666–ofaf666.

Masiá, Mar, Marta Fernández‐González, Nieves Gonzalo-Jiménez, et al.. (2025). Impact of Switching to Long-Acting Injectable Cabotegravir Plus Rilpivirine on Rectal HIV-1 RNA Shedding and Implications for Transmission Risk. The Journal of Infectious Diseases. 231(4). e792–e802. 1 indexed citations

Padilla, Sergio, Javier García‐Abellán, José Alberto García, et al.. (2024). Long COVID across SARS-CoV-2 variants, lineages, and sublineages. iScience. 27(4). 109536–109536. 8 indexed citations

Gutiérrez, Félix, Marta Fernández‐González, Enrique Barrajón‐Catalán, et al.. (2024). Virological History Predicts Non-sustained Viral Suppression With Long-Acting Cabotegravir and Rilpivirine Therapy, Independent of Pharmacokinetic Parameters. Clinical Infectious Diseases. 80(4). 842–853. 15 indexed citations

García‐Fernández, Lorena, Verónica Romero‐Ferreiro, Sergio Padilla, et al.. (2024). Transcranial direct current stimulation (tDCS) enhances cognitive function in schizophrenia: A randomized double-blind sham-controlled trial. Psychiatry Research. 344. 116308–116308. 2 indexed citations

Fernández‐González, Marta, Vanesa Agulló, José Alberto García, et al.. (2023). T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants. The Journal of Infectious Diseases. 228(9). 1240–1252. 3 indexed citations

Masiá, Mar, Marta Fernández‐González, Sergio Padilla, et al.. (2020). Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study. EBioMedicine. 60. 102999–102999. 53 indexed citations

10.

Masiá, Mar, et al.. (2017). Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial. PLoS ONE. 12(4). e0175634–e0175634. 11 indexed citations

11.

Merchante, Nicolás, Esperanza Merino, José López-Aldeguer, et al.. (2012). Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain. Clinical Infectious Diseases. 56(1). 143–150. 51 indexed citations

12.

Masiá, Mar, Sergio Padilla, Catalina Robledano, et al.. (2011). Short Communication: Early Changes in Parathyroid Hormone Concentrations in HIV-Infected Patients Initiating Antiretroviral Therapy with Tenofovir. AIDS Research and Human Retroviruses. 28(3). 242–246. 51 indexed citations

13.

Ramos, José Manuel, Mar Masiá, Sergio Padilla, Eduardo García-Pachón, & Félix Gutiérrez. (2009). Producción española sobre tuberculosis a través del MEDLINE (1997–2006). Archivos de Bronconeumología. 45(6). 271–278. 11 indexed citations

14.

Bernal, Enrique, Mar Masiá, Sergio Padilla, & Félix Gutiérrez. (2008). High-Density Lipoprotein Cholesterol in HIV-Infected Patients: Evidence for an Association with HIV-1 Viral Load, Antiretroviral Therapy Status, and Regimen Composition. AIDS Patient Care and STDs. 22(7). 569–575. 42 indexed citations

15.

Masiá, Mar, Sergio Padilla, Victoria Sánchez, et al.. (2008). Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial. European Journal of Clinical Microbiology & Infectious Diseases. 27(7). 597–605. 16 indexed citations

16.

Masiá, Mar, Félix Gutiérrez, Sergio Padilla, et al.. (2006). Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors. Clinical Microbiology and Infection. 13(2). 153–161. 25 indexed citations

17.

Padilla, Sergio, et al.. (2005). Low Frequency of Renal Function Impairment During One-Year of Therapy with Tenofovir-Containing Regimens in the Real-World: A Case-Control Study. AIDS Patient Care and STDs. 19(7). 421–424. 42 indexed citations

18.

Gutiérrez, Félix, et al.. (2005). Prediction of Neuropsychiatric Adverse Events Associated with Long-Term Efavirenz Therapy, Using Plasma Drug Level Monitoring. Clinical Infectious Diseases. 41(11). 1648–1653. 185 indexed citations

19.

Ramos, José Manuel, et al.. (2005). Características clínicas y epidemiológicas de la infección por el VIH en extranjeros en Elche, España (1998-2003). Enfermedades Infecciosas y Microbiología Clínica. 23(8). 469–473. 12 indexed citations

20.

Santos‐Ocaña, Carlos, Quang Minh Thai, Catherine F. Clarke, Sergio Padilla, & Plácido Navas. (2002). Uptake of Exogenous Coenzyme Q and Transport to Mitochondria Is Required for bc1 Complex Stability in Yeast coq Mutants. Journal of Biological Chemistry. 277(13). 10973–10981. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact